In this podcast to mark Lung Cancer Awareness Month, Optimum’s Richard Staines speaks to Roman Thomas, CEO and founder of Disco Pharmaceuticals, on breakthroughs that have improved patient outcomes, and the company’s efforts to help develop new therapies with its “surfaceome” technology. <hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

In this podcast to mark Lung Cancer Awareness Month, Optimum’s Richard Staines speaks to Roman Thomas, CEO and founder of Disco Pharmaceuticals, on breakthroughs that have improved patient outcomes, and the company’s efforts to help develop new therapies with its “surfaceome” technology. Hosted on Acast. See acast.com/privacy for more information.

In this podcast to mark Lung Cancer Awareness Month, Optimum’s Richard Staines speaks to Roman Thomas, CEO and founder of Disco Pharmaceuticals, on breakthroughs that have improved patient outcomes, and the company’s efforts to help develop new therapies with its “surfaceome” technology.&nbsp; Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for more information.

DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology

<a href="https://www.optimumcomms.com/podcast/" rel="noopener noreferrer" target="_blank">Optimum Insights: Interviews with industry leaders of the healthcare sector in regular episodes highlighting the latest innovation and developments in life sciences.</a>Follow us on <a href="https://www.linkedin.com/company/optimum-strategic-communications/" rel="noopener noreferrer" target="_blank">Linkedin</a> and <a href="https://twitter.com/OptimumComms" rel="noopener noreferrer" target="_blank">Twitter</a> for news and highlights on the life sciences industry. Reach out via our contact page on our website: <a href="https://www.optimumcomms.com/" rel="noopener noreferrer" target="_blank">www.optimumcomms.com</a><hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

Business

Science

Health & Fitness

Optimum Insights: Interviews with industry leaders of the healthcare sector in regular episodes highlighting the latest innovation and developments in life sciences. Follow us on Linkedin and Twitter for news and highlights on the life sciences industry. Reach out via our contact page on our website: www.optimumcomms.com Hosted on Acast. See acast.com/privacy for more information.

<a href="https://www.optimumcomms.com/podcast/" rel="noopener noreferrer">Optimum Insights: Interviews with industry leaders of the healthcare sector in regular episodes highlighting the latest innovation and developments in life sciences.</a>Follow us on <a href="https://www.linkedin.com/company/optimum-strategic-communications/" rel="noopener noreferrer">Linkedin</a> and <a href="https://twitter.com/OptimumComms" rel="noopener noreferrer">Twitter</a> for news and highlights on the life sciences industry. Reach out via our contact page on our website: <a href="https://www.optimumcomms.com/" rel="noopener noreferrer">www.optimumcomms.com</a> Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for more information.

Share DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology

Sign up to save your podcasts

DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology

DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology